Blog

The CNN Fear & Greed Index currently signals fear, suggesting investors are quite pessimistic about the outlook for the stock market. There are plenty of reasons for them to be worried, as high

Investors have become increasingly pessimistic over the past year, worried that runaway inflation would cause the economy to sink into a recession. That concern has been amplified by a series of

It's hard to find winners in the current stock market. So when a company's shares surge more than 20% in a single day, many investors ask: Is it too late to buy?

Undoubtedly, more than a few people

As interest rates move higher, more and more market participants get concerned about a potential recession. Historically, Federal Reserve policy hits the market with a lag, which is generally

For many investors, this has shaped up to be one of the most challenging years on record. Since hitting their respective all-time highs between mid-November and the first week of January, the

As discretionary funds get crunched, many travelers may cut trips or at least reduce their stay length. Another way they may look to reduce the trip cost while maintaining the travel is to stay at

Wall Street has been known to get irrational, which can open up long-term opportunities for investors that buy and sell based on decades-long plans, not days-long. The latest example of this

It's no secret that stocks with exposure to the housing market have had a rough year in 2022. Rising interest rates caused mortgage rates to spike, and concerns about the housing demand cooling down

Earlier this month, the Dow Jones Industrial Average temporarily slipped back into bear market territory. It was down as much as 22% at one point, but has recovered somewhat and is currently down

There's no sugarcoating it: This has been a miserable year for professional and everyday investors. Regardless of whether you're new to investing or have been putting your money to work on Wall

It's hardly a secret that inflation has reached astronomical levels in 2022. That's put a huge burden on seniors, many of whom get the bulk of their income from Social Security.

Meanwhile, Social

Image source: The Motley Fool.

Netflix (NASDAQ: NFLX)Q3 2022 Earnings CallOct 18, 2022, 6:00 p.m. ET

Spencer Wang

Continue reading

Source Fool.com

For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.

With a few more

For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.

When the going

For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.

Goldman Sachs

Image source: The Motley Fool.

Intuitive Surgical (NASDAQ: ISRG)Q3 2022 Earnings CallOct 18, 2022, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

Shares of Amazon (NASDAQ: AMZN) climbed 2.3% on Tuesday, following some positive notes from analysts. 

Barclays analyst Ross Sandler believes Amazon's stock is a buy ahead of its upcoming earnings

Next-generation healthcare company Babylon Holdings (NYSE: BBLN) was hardly the picture of health on Tuesday. The company's stock took a more than 15% tumble on the day, due largely to a dilutive

Wall Street stayed in a good mood on Tuesday, building on Monday's gains with further advances. The size of the move higher wasn't quite as big as yesterday, but the Dow Jones Industrial Average

Carvana (NYSE: CVNA) stock had only a ho-hum day on Tuesday, dragging slightly behind the broader stock market. The big auto retailer's shares bumped up only slightly, not quite hitting the 1% mark

A good day for the stock market isn't necessary beneficial for social media king Meta Platforms (NASDAQ: META) too. This was proven on Tuesday, as the company's stock slumped by nearly 1% while the

On Tuesday, star biotech stock Moderna (NASDAQ: MRNA) had one of those rare days in which it declined in price while the broader market rose. On the back of a fresh analyst price-target cut, the

A tweet from a U.S. senator was the motor driving Mind Medicine (NASDAQ: MNMD) stock up at near double-digit rates on Tuesday. Although the tweet didn't mention the company by name, it did strongly

Shares of Target (NYSE: TGT) popped 5.4% on Tuesday, following bullish analyst commentary. 

Jefferies analyst Corey Tarlowe boosted the firm's rating on Target's stock from hold to buy. He sees the

Legend Biotech (NASDAQ: LEGN), a commercial-stage Chinese biotech company that specializes in oncology and cell therapies, saw its shares rise 14.2% on Tuesday. The stock closed on Monday at $40.20